Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01745393 · ClinicalTrials.gov registry record · NA

Kids Safe and Smokefree (KiSS)

A NA study, sponsored by Temple University.

Completed
Registry status
NA
Development phase
327
Enrollment target

NCT01745393: Completed NA study, sponsored by Temple University.

NCT01745393 is a NA study that has completed, run by Temple University. The registered enrollment target is 327 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01745393, a NA study, has completed, sponsored by Temple University.

COMPLETED
Registry status
NA
Development phase
327 participants
Enrollment target

Study Summary

The study's primary aim is to test the hypothesis that an intervention integrating pediatric clinic-level quality improvement with home-level behavioral counseling (CQI+BC) will result in greater reductions in child cotinine (a biomarker of secondhand smoke exposure) and reported cigarettes exposed/day than a clinic-level quality improvement plus attention control intervention (CQI+A). A secondary aim is to test the hypothesis that relative to CQI+A, CQI+BC will result in higher cotinine-verified, 7-day point prevalence quit rate among parents.

Primary Outcome

Child urine cotinine is a biomarker for assessing second-hand smoke exposure. We anticipate the CQI+BC treatment group will experience a greater reduction in child urine cotinine over time than the CQI+A control group.

Interventions

  • BEHAVIORAL Clinic Quality Improvement + Behavioral Counseling
  • BEHAVIORAL Clinic Quality Improvement + Attention Control

Trial Details

FieldValue
Enrollment Target 327 participants
Start Date 2012-03
Est. Completion 2016-06
Phase NA
Temple University

163 total trials

What the finished NCT01745393 record still lists

NCT01745393 is an interventional study that assigns participants to a tested intervention. The registered 327 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).

The record links to 0 conditions, and to 2 interventions - of which Clinic Quality Improvement + Behavioral Counseling is the first listed.

NCT01745393 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01745393 about?

NCT01745393 is a clinical study titled "Kids Safe and Smokefree (KiSS)". The study's primary aim is to test the hypothesis that an intervention integrating pediatric clinic-level quality improvement with home-level behavioral counseling (CQI+BC) will result in greater reductions in child cotinine (a biomarker of secondhand smoke exposure) and reported cigarettes exposed/...

What is the current status of trial NCT01745393?

This trial is currently completed. It is a NA study. The enrollment target is 327 participants. The study started on 2012-03. Estimated completion is 2016-06.

What interventions are being tested in trial NCT01745393?

The interventions under investigation include: Clinic Quality Improvement + Behavioral Counseling (BEHAVIORAL), Clinic Quality Improvement + Attention Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT01745393?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01745393's enrollment target sits among peer trials

327 309th of 2000 higher than 1,691 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04486378 · 327 participants · Phase 2

    A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

  • NCT06370182 · 327 participants · NA

    Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter

  • NCT05156983 · 328 participants · Phase 3

    A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

  • NCT05380401 · 328 participants · NA

    Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01745393, the US trial registry maintained by the National Library of Medicine. NCT01745393 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.